C-reactive protein to albumin ratio as a predictor of contrast-induced nephropathy; a systematic review and meta-analysis
Journal of Renal Injury Prevention · 18.12.2025 · 15 (1) · e38399
DOI: 10.34172/jrip.2025.38399 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Renal Injury Prevention, online erschienen am 18.12.2025. Verfasst von Sam Mirfendereski und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
The C-reactive protein-to-albumin ratio (CAR) is a marker of inflammation that has been found to be more informative in assessing inflammation conditions in cardiovascular patients than the C-reactive protein (CRP) or albumin (ALB) levels only. Since inflammation has been identified as a factor causing contrast-induced nephropathy (CIN), this research seeks to establish the correlation between the CAR and the risk of CIN. Materials and Methods: This systematic review and meta-analysis was conducted according to the PRISMA protocol. The Cochrane, PubMed, ProQuest, and Web of Science databases, as well as the Google Scholar search engine, were searched with no time limit up to August 8, 2024. Data were analyzed using STATA 14 software at a significance level of P < 0.05 for all tests.
Results
The findings of five reviewed studies with a total number of 1,442 participants showed a statistically significant positive correlation between CAR (OR: 2.11, 95% CI: 1.41, 3.14) and CRP (OR: 1.11, 95% CI: 1.02, 1.20), with an increase in the risk of CIN. However, no statistically significant associations were found between the patient age (OR: 1.02, 95% CI: 0.96, 1.09), albumin level (OR: 0.64, 95% CI: 0.14, 2.90), hypertension (OR: 2.12, 95% CI: 0.86, 5.21), and diabetes mellitus (OR: 0.80, 95% CI: 0.28, 2.29) variables and the risk of CIN.
Conclusion
Elevated CAR and CRP are CIN risk factors that can be evaluated to provide a good prognosis of this condition. Nevertheless, albumin levels were not significantly related to the development of CIN. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD42024580053) and Research Registry (UIN: reviewregistry1874) websites.
Zitieren
APA
Mirfendereski, S., Ahmadnia, M., & Dehkordi, A. H. (2025). C-reactive protein to albumin ratio as a predictor of contrast-induced nephropathy; a systematic review and meta-analysis. Journal of Renal Injury Prevention, 15(1), e38399. https://doi.org/10.34172/jrip.2025.38399
Vancouver
Mirfendereski S, Ahmadnia M, Dehkordi AH. C-reactive protein to albumin ratio as a predictor of contrast-induced nephropathy; a systematic review and meta-analysis. Journal of Renal Injury Prevention. 2025;15(1):e38399. doi:10.34172/jrip.2025.38399
BibTeX
@article{Mirfendereski2025,
author = {Mirfendereski, Sam and Ahmadnia, Mahdieh and Dehkordi, Ali Hasanpour},
title = {C-reactive protein to albumin ratio as a predictor of contrast-induced nephropathy; a systematic review and meta-analysis},
journal = {Journal of Renal Injury Prevention},
year = {2025},
volume = {15},
number = {1},
pages = {e38399},
doi = {10.34172/jrip.2025.38399}
}
EUVIMED